Standard physicals are, well, pretty standard. During a visit geared more toward detecting disease than preventing it, your doctor makes you cough and checks your numbers. If there’s an abnormality -- your blood pressure has spiked or your liver enzymes are elevated -- it’s your schedule that suffers as you’re shuttled between specialists.
Evidence against Mathew Martoma, the former SAC Capital Advisors LP portfolio manager charged with insider trading, includes e-mails from SAC and third parties and trading records, federal prosecutors said.
About 1 in 8 Americans at least 60 years old reported confusion or memory loss in the preceding 12 months, according to health officials highlighting the need to be alert for early signs of dementia or Alzheimer’s disease.
Baxter International Inc.’s Gammagard failed to help patients with Alzheimer’s disease in a late-stage study, adding to a string of failures to develop a treatment for the most common form of dementia.
Elan Corp. considered buying New York investment firm Royalty Pharma last year, about six months before Royalty Pharma turned around with an acquisition proposal for Elan that’s now valued at about $5.7 billion.